Director at Corcept Therapeutics Incorporated (NASDAQ:CORT) Leonard G Baker reported having purchased 74,113 shares of common stock, at a price of $2.32 per share, acquired from Sutter Hill Entrepreneurs Fund (QP), L.P. (“SHQP”), as Managing Director of the General Partner of SHQP. In addition, Mr. Baker bought 29,273 shares at this $253.61 million Market Cap Company, at a price of $2.32 per share. These shares were procured from Sutter Hill Entrepreneurs Fund (AI), L.P. (“SHAI”), enterprise from which Mr. Baker is a Managing Director of the General Partner. Mr. Baker previously reported beneficial ownership of such shares indirectly through SHQP, and SHAI, disclaiming beneficial ownership of these shares except as to the reporting person’s pecuniary interest in the partnership. The purchase constituted a change in the form of ownership of the shares previously owned by Mr. Baker from one form of indirect ownership to another. Following this transaction, Mr. Baker owns 578,389 directly, and another 8,910,769 through its different indirect holdings.
Other important insider purchases at Corcept Therapeutics Incorporated (NASDAQ:CORT) have been registered over the course of this year. Director Joseph Cook acquired 200,000 over the course of this year, at prices ranging from $ 2.02 to $ 1.79 per share. Moreover, Director Daniel Bradbury purchased during the last reported quarter 138,925 shares, at an average Price of $ 1.81 per share, and Director David Mahoney purchased as well this stock during Q2: 100,000 shares, at a price of $ 1.85 per share.
Disclosure: None.
Suggested Reading:
The 13 Most Expensive Headphones in the World to Represent
The Top 20 Wealthiest Soccer Teams in 2014
